ℹ️ Compiled from public regulatory records · Last regulator revision: April 24, 2026🚩 Report this page
Protease
Active ingredient
Sold as DIGESTIVE ENZYMES
GB MHRACA Health Canada
- Drug class
- -
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 2
Overview
Protease is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | April 24, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
GBUnited Kingdom· MHRA
1 product
Uses
Not applicable.
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (1)
Sources & citations
- [1]MHRA (UK) · PLPI151840534 · revised April 24, 2026
- [2]Health Canada (DPD) · 02236927 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.